Table 3.
Model 1a |
Model 2b |
Model 3c |
||||
---|---|---|---|---|---|---|
Characteristic | β | P Value | β | P Value | β | P Value |
Cardiovascular measures | ||||||
| ||||||
baPWV, cm/s | .196 | .07 | .206 | .06 | .177 | .08 |
| ||||||
cfPWV, cm/s | .595 | .001 | .572 | .001 | .522 | .002 |
| ||||||
hfPWV, cm/s | .467 | .003 | .452 | .004 | .403 | .007 |
| ||||||
faPWV, cm/s | .052 | .34 | .053 | .34 | .048 | .37 |
| ||||||
Pulse rate, beats/min | .032 | .46 | .029 | .49 | .044 | .39 |
| ||||||
SBP, mm Hg | .016 | .61 | .015 | .62 | … | … |
| ||||||
DBP, mm Hg | .000 | .96 | .000 | .98 | … | … |
| ||||||
PP, mm Hg | .029 | .48 | .031 | .48 | … | … |
Abbreviations: See Table 2; ellipses, adjustment for pulse pressure is not appropriate for blood pressure measures.
P value adjusted for age, sex, and time between Ap scans.
P value adjusted for age, sex, antihypertensive medication use, body mass index, time between Aβ scans, and history of cardiovascular disease.
P value adjusted for age, sex, antihypertensive medication use, body mass index, time between Aβ scans, and PP.